Yuan TZ, Zhan ZJ, Qian CN. New frontiers in proton therapy: applications in cancers. Cancer Commun (Lond). 2019;39(1):61.

Article  Google Scholar 

Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25(8):953–64.

PubMed  Article  Google Scholar 

Schulz-Ertner D, Jäkel O, Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol. 2006;16(4):249–59.

PubMed  Article  Google Scholar 

LaRiviere MJ, Santos PMG, Hill-Kayser CE, Metz JM. Proton Therapy. Hematol Oncol Clin North Am. 2019;33(6):989–1009.

PubMed  Article  Google Scholar 

Krämer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat. 2003;2(5):427–36.

PubMed  Article  Google Scholar 

Mladenov E, Saha J, Iliakis G. Processing-Challenges Generated by Clusters of DNA Double-Strand Breaks Underpin Increased Effectiveness of High-LET Radiation and Chromothripsis. In: Zhang Y, editor. Chromosome Translocation. Singapore: Springer Singapore; 2018. p. 149–68.

Chapter  Google Scholar 

Suetens A, Konings K, Moreels M, Quintens R, Verslegers M, Soors E, et al. Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells. Front Oncol. 2016;6:87.

PubMed  PubMed Central  Article  Google Scholar 

Held KD, Kawamura H, Kaminuma T, Paz AE, Yoshida Y, Liu Q, et al. Effects of Charged Particles on Human Tumor Cells. Front Oncol. 2016;6:23.

PubMed  PubMed Central  Article  Google Scholar 

Antonovic L, Lindblom E, Dasu A, Bassler N, Furusawa Y, Toma-Dasu I. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes. J Radiat Res. 2014;55(5):902–11.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lopez Perez R, Nicolay NH, Wolf JC, Frister M, Schmezer P, Weber KJ, et al. DNA damage response of clinical carbon ion versus photon radiation in human glioblastoma cells. Radiother Oncol. 2019;133:77–86.

CAS  PubMed  Article  Google Scholar 

Rieken S, Habermehl D, Wuerth L, Brons S, Mohr A, Lindel K, et al. Carbon ion irradiation inhibits glioma cell migration through downregulation of integrin expression. Int J Radiat Oncol Biol Phys. 2012;83(1):394–9.

CAS  PubMed  Article  Google Scholar 

Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;65(1):113–20.

CAS  PubMed  Google Scholar 

Moncharmont C, Levy A, Guy J-B, Falk AT, Guilbert M, Trone J-C, et al. Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol Hematol. 2014;92(2):133–42.

PubMed  Article  Google Scholar 

Park JM, Kim JI, Wu HG. Technological Advances in Charged-Particle Therapy. Cancer Res Treat. 2021;53(3):635–40.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Eichkorn T, König L, Held T, Naumann P, Harrabi S, Ellerbrock M, et al. Carbon ion radiation therapy: one decade of research and clinical experience at heidelberg ion beam therapy center. Int J Radiat Oncol Biol Phys. 2021;111(3):597–609.

PubMed  Article  Google Scholar 

Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123(4):465–72.

CAS  PubMed  Article  Google Scholar 

Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma Nat Rev Dis Primers. 2019;5(1):11.

PubMed  Article  Google Scholar 

Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr. 2019;24(4):353–63.

PubMed  Article  Google Scholar 

Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018;19(6):785–98.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250(4985):1233–8.

CAS  PubMed  Article  Google Scholar 

Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990;348(6303):747–9.

CAS  PubMed  Article  Google Scholar 

Rausch T, Jones DT, Zapatka M, Stütz AM, Zichner T, Weischenfeldt J, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell. 2012;148(1–2):59–71.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144(1):27–40.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Magrangeas F, Avet-Loiseau H, Munshi NC, Minvielle S. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood. 2011;118(3):675–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012;483(7391):589–93.

CAS  PubMed  Article  Google Scholar 

Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, Ghelli Luserna di Rorá A, et al. Chromothripsis in acute myeloid leukemia: biological features and impact on survival. Leukemia. 2018;32(7):1609–20.

Simovic M, Bolkestein M, Moustafa M, Wong JKL, Körber V, Benedetto S, et al. Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model. Neuro Oncol. 2021;23(12):2028–41.

PubMed  PubMed Central  Article  Google Scholar 

Chiblak S, Tang Z, Lemke D, Knoll M, Dokic I, Warta R, et al. Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche. JCI Insight. 2019;4(2).

Brownstein JM, Wisdom AJ, Castle KD, Mowery YM, Guida P, Lee CL, et al. Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma. Mol Cancer Ther. 2018;17(4):858–68.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Johnston DL, Keene D, Strother D, Taneva M, Lafay-Cousin L, Fryer C, et al. Survival Following Tumor Recurrence in Children With Medulloblastoma. J Pediatr Hematol Oncol. 2018;40(3):e159–63.

PubMed  Article  Google Scholar 

Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, et al. Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. J Neurooncol. 2016;129(3):515–24.

PubMed  PubMed Central  Article  Google Scholar 

Balter-Seri J, Mor C, Shuper A, Zaizov R, Cohen IJ. Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse. Cancer. 1997;79(6):1241–7.

CAS  PubMed  Article  Google Scholar 

Gajjar A, Pizer B. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors. Pediatr Blood Cancer. 2010;54(4):649–51.

PubMed  Article  Google Scholar 

Vanner RJ, Remke M, Gallo M, Selvadurai HJ, Coutinho F, Lee L, et al. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell. 2014;26(1):33–47.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang L, He X, Liu X, Zhang F, Huang LF, Potter AS, et al. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell. 2019;36(3):302-18.e7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature. 2016;529(7586):351–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJH, Witt H, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature. 2012;482(7386):529–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Peitzsch C, Kurth I, Ebert N, Dubrovska A, Baumann M. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology. Int J Radiat Biol. 2019;95(7):900–11.

CAS  PubMed  Article  Google Scholar 

Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer Stem Cells-Key Players in Tumor Relapse. Cancers (Basel). 2021;13(3).

Lathia J, Liu H, Matei D. The Clinical Impact of Cancer Stem Cells. Oncologist. 2020;25(2):123–31.

PubMed  Article  Google Scholar 

Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741–51.

CAS  PubMed